Skip to content
Screener

Ashland ASH Life Sciences — Total Assets

Other segment segments

Unallocated And Other
$1.35B+10.0%
Specialty Additives
$964M-8.0%
Personal Care And Household
$705M+0.9%
Intermediates And Solvents
$107M-9.3%

Similar metrics at other companies

VAT
VATELife Sciences — Total Assets
$8.5M-27.4%
Bio-Rad Laboratories logo
BIOLife Science — Total Assets
$301.7M-2.1%
RCM Technologies logo
RCMTLife Sciences Data Solutions — Total Assets
$13.53M-69.4%
STERIS logo
STEHealthcare Products and Life Sciences — Total Assets
$7.14B+4.1%
Brighthouse Financial logo
BHFLife — Total Assets
$28.06B+4.6%
IDEX logo
IEXHealth & Science Technologies — Total Assets
$4.28B+0.7%

Other financials

Income statement

See full
Revenue$497.0M+7.3%
Gross profit$170.0M+28.8%
Operating income$43.0M+106%
Net income$16.0M+102%
EPS (diluted)$0.35+102%

Balance sheet

See full
Cash & equivalents$440.0M+113%
Total debt$1.5B-0.6%
Total equity$1.9B-1.0%
Total assets$4.6B-0.9%

Cash flow

See full
Operating cash flow$120.0M+4.3%
CapEx$20.0M0.0%
Free cash flow$100.0M+5.3%

Valuation

See full
Market cap$3.32B+40.6%
Enterprise value$4.35B+19.7%
P/E165.9×—
P/S1.8×+0.5×

Profitability

See full
Gross margin31.5%+1.4pp
Operating margin4.1%—
Net margin1.1%+0.5pp
FCF margin13.6%+9.7pp

Returns & leverage

See full
Return on equity1.1%+0.5pp
Debt / equity0.8×0.0×
Current ratio3×+0.4×

Where this comes from

Reported directly by Ashland in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: Ashland’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 5:17 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-324226
(In millions - unaudited)June 30 / 2026September 30 / 2025
Assets
Life Sciences$1,454$1,498
Personal Care705751
Specialty Additives9641,020
Intermediates107116
Unallocated and other1,3481,226
$4,578$4,611
Property, plant and equipment - net

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Ashland's life sciences — total assets?
Ashland (ASH) reported life sciences — total assets of $1.45B in Q2 2026.
How has Ashland's life sciences — total assets changed year-over-year?
Ashland's life sciences — total assets decreased by 5.0% year-over-year, from $1.53B to $1.45B.
What is the long-term trend for Ashland's life sciences — total assets?
Over 4 years (2021 to 2025), Ashland's life sciences — total assets has grown at a -3.7% compound annual growth rate (CAGR), from $7.82B to $6.72B.
What does life sciences — total assets mean?
This metric represents the total economic resources controlled by the Life Sciences segment, including inventory, property, plant, equipment, and intangible assets. It provides a measure of the scale and capital base required to support the segment's revenue generation. Analyzing this helps evaluate the asset utilization and return on capital employed for the business unit.

Ask your AI about Ashland's life sciences — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude